Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study
Open Access
- 25 October 2023
- journal article
- research article
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 31 (1) , 1-16
Abstract
Background: Accidental hypothermia, recognized by core temperature below 35 °C, is a lethal condition with a mortality rate up to 25%. Hypothermia-induced cardiac dysfunction causing increased total peripheral resistance and reduced cardiac output contributes to the high mortality rate in this patient group. Recent studies, in vivo and in vitro, have suggested levosimendan, milrinone and isoprenaline as inotropic treatment strategies in this patient group. However, these drugs may pose increased risk of ventricular arrhythmias during hypothermia. Our aim was therefore to describe the effects of levosimendan, milrinone and isoprenaline on the action potential in human cardiomyocytes during hypothermia. Methods: Using an experimental in vitro-design, levosimendan, milrinone and isoprenaline were incubated with iCell2 hiPSC-derived cardiomyocytes and cellular action potential waveforms and contraction were recorded from monolayers of cultured cells. Experiments were conducted at temperatures from 37 °C down to 26 °C. One-way repeated measures ANOVA was performed to evaluate differences from baseline recordings and one-way ANOVA was performed to evaluate differences between drugs, untreated control and between drug concentrations at the specific temperatures. Results: Milrinone and isoprenaline both significantly increases action potential triangulation during hypothermia, and thereby the risk of ventricular arrhythmias. Levosimendan, however, does not increase triangulation and the contractile properties also remain preserved during hypothermia down to 26 °C. Conclusions: Levosimendan remains a promising candidate drug for inotropic treatment of hypothermic patients as it possesses ability to treat hypothermia-induced cardiac dysfunction and no increased risk of ventricular arrhythmias is detected. Milrinone and isoprenaline, on the other hand, appears more dangerous in the hypothermic setting.Keywords
Funding Information
- Helse Nord RHF (HNF1337-17)
- UiT The Arctic University of Norway
This publication has 47 references indexed in Scilit:
- The pattern of Tpeak–Tend and QT interval, and J wave during therapeutic hypothermiaJournal of Electrocardiology, 2014
- Role of calcium desensitization in the treatment of myocardial dysfunction after deep hypothermic circulatory arrestCritical Care, 2013
- The benign nature of mild induced therapeutic hypothermia—Induced long QTcInternational Journal of Cardiology, 2013
- Accidental HypothermiaNew England Journal of Medicine, 2012
- Levosimendan is superior to epinephrine in improving myocardial function after cardiopulmonary bypass with deep hypothermic circulatory arrest in ratsThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Effects of Hypothermia on Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2010
- Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinoneEuropean Journal of Anaesthesiology, 2009
- Changes in cardiovascular β-adrenoceptor responses during hypothermiaCryobiology, 2008
- Clinical Pharmacology of LevosimendanClinical Pharmacokinetics, 2007
- Phosphorylation of Troponin I Controls Cardiac Twitch DynamicsCirculation Research, 2002